Renovorx highlights key leadership promotions

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today highlighted the recent key leadership promotions of leesa gentry to chief clinical officer and ronald b. kocak, cpa to principal accounting officer. shaun bagai, chief executive officer of renovorx, commented, “we are delighted to promote leesa and ron to their new.
RNXT Ratings Summary
RNXT Quant Ranking